Eunice Wang, MD
Roswell Park Cancer Institute · Roswell Park Cancer Institute, Buffalo, New York, United States, 14263 · Roswell Park Cancer Institute - Buffalo, NY
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eunice Wang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04269213 · CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years OldRoswell Park Cancer Institute · completed · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Secondary Acute Myeloid Leukemia · principal investigator
- Ph1NCT03564288 · Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)Oscotec Inc. · completed · Acute Myeloid Leukemia · principal investigator
- Ph3NCT03250338 · Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AMLArog Pharmaceuticals, Inc. · completed · Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations · principal investigator
- Ph2NCT01564277 · Rasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesRoswell Park Cancer Institute · terminated · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) · principal investigator
- Ph1/Ph2NCT01349049 · Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)Daiichi Sankyo · completed · Acute Myeloid Leukemia · principal investigator
- Ph1NCT01014546 · Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With MyelofibrosisRoswell Park Cancer Institute · terminated · Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Administrative CoreP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dale Henry · fiscal years 2008 to 2026Named on NCT01564277
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.